India's First MRNA Covid Vaccine Safe In Early Trials, Say Regulators
[email protected]08 Sep, 2021News
India's first and only mRNA vaccine against Covid-19 on Tuesday received regulatory approval for advanced clinical trials to examine its protective efficacy, raising the hopes of its availability for public use after a few months. ?It is a matter of pride that Nation?s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India has approved the phase II/III trial. This is an important milestone in our indigenous vaccine development mission and positions India on the global map for novel vaccine development,? said Renu Swarup, Secretary, DBT.
Related Bookmarks
- click to read more
- Adtech Leader Ezoic to Invest $12.4 Million Directly in Customers
- Digital Marketing Leader Sojern Partners with Roiback
- Drips Unveils Conversational AI Platform at Contact.io Conference
- Oxford brunch Bar | Tasty & healthy breakfast | Breakfast brunch bar
- https://www.stattimes.com/news/bbam-to-lease-two-airbus-a321p2f-to-lufthansa-cargo-air-cargo/
- Different Types of Tyre Treads and Their Uses
- Bitcoin Profit
- GEODIS in Hong Kong is accredited as an Authorized Economic Operator
- Best Circulation Pump Supplier
Recent Profiles
Imperial Salon And Spa Ii
Katie Myers, Realtor
Ameen
Brenda Allen
Puja Car Detailing Studio
Bom88icu
Foxedosports
Pmcc Services Llc
Kc Improvements - Driveways Henley On Thames
K9win Autos